Signaling-Biased and Constitutively Active Dopamine D2 Receptor Variant.


Journal

ACS chemical neuroscience
ISSN: 1948-7193
Titre abrégé: ACS Chem Neurosci
Pays: United States
ID NLM: 101525337

Informations de publication

Date de publication:
02 06 2021
Historique:
pubmed: 12 5 2021
medline: 22 6 2021
entrez: 11 5 2021
Statut: ppublish

Résumé

A dopamine D2 receptor mutation was recently identified in a family with a novel hyperkinetic movement disorder. Compared to the wild type D2 receptor, the novel allelic variant D2-I

Identifiants

pubmed: 33974399
doi: 10.1021/acschemneuro.0c00712
pmc: PMC8528033
mid: NIHMS1708496
doi:

Substances chimiques

Dopamine Agonists 0
Receptors, Dopamine D2 0
Quinpirole 20OP60125T
Cyclic AMP E0399OZS9N

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

1873-1884

Subventions

Organisme : NIDA NIH HHS
ID : R01 DA034388
Pays : United States
Organisme : BLRD VA
ID : I01 BX003279
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA004523
Pays : United States
Organisme : NIDA NIH HHS
ID : F31 DA047007
Pays : United States
Organisme : NINDS NIH HHS
ID : R21 NS117713
Pays : United States

Références

Nat Chem Biol. 2012 Jul;8(7):622-30
pubmed: 22634635
J Recept Signal Transduct Res. 2007;27(1):47-65
pubmed: 17365509
Neurosignals. 2009;17(1):23-41
pubmed: 19212138
J Biol Chem. 2007 Apr 6;282(14):10576-84
pubmed: 17283075
Cell Signal. 2018 Jan;41:75-81
pubmed: 28716664
Nature. 2018 Mar 8;555(7695):269-273
pubmed: 29466326
Mol Pharmacol. 1996 Oct;50(4):966-76
pubmed: 8863843
Sci Signal. 2018 Jul 17;11(539):
pubmed: 30018083
Genesis. 2006 Aug;44(8):383-90
pubmed: 16865686
Nat Neurosci. 2011 Jul 10;14(8):1033-8
pubmed: 21743470
Mol Pharmacol. 2000 May;57(5):890-8
pubmed: 10779371
Proteins. 2009;77 Suppl 9:114-22
pubmed: 19768677
Mol Pharmacol. 1999 Jul;56(1):175-84
pubmed: 10385699
Nature. 2020 Aug;584(7819):125-129
pubmed: 32528175
J Biol Chem. 1991 May 25;266(15):9987-96
pubmed: 1851762
Mov Disord. 2021 Mar;36(3):729-739
pubmed: 33200438
ACS Chem Neurosci. 2020 Mar 18;11(6):939-951
pubmed: 32077679
Annu Rev Physiol. 2007;69:451-82
pubmed: 17037978
Br J Pharmacol. 2003 Mar;138(5):775-86
pubmed: 12642378
J Biol Chem. 1992 Jan 25;267(3):1430-3
pubmed: 1346134
Nature. 2007 Nov 15;450(7168):383-7
pubmed: 17952055
Proc Natl Acad Sci U S A. 2013 Jan 15;110(3):942-7
pubmed: 23277586
Front Mol Neurosci. 2019 May 01;12:104
pubmed: 31118885
J Biol Chem. 2009 May 29;284(22):15038-51
pubmed: 19332542
Neuropsychopharmacology. 2018 Apr;43(5):1164-1173
pubmed: 29068002
PLoS One. 2016 Jan 07;11(1):e0146612
pubmed: 26741139
Prog Brain Res. 2014;211:235-54
pubmed: 24968783
J Neurochem. 2001 Apr;77(2):493-504
pubmed: 11299312
Methods Enzymol. 1997;277:396-404
pubmed: 9379925
Proteins. 2004 Dec 1;57(4):678-83
pubmed: 15390263
Neuron. 2018 May 2;98(3):575-587.e4
pubmed: 29656874
Cell. 2005 Jul 29;122(2):261-73
pubmed: 16051150
J Biol Chem. 2014 Nov 28;289(48):33663-75
pubmed: 25336643
Elife. 2015 Aug 26;4:
pubmed: 26308580
J Biol Chem. 2001 Oct 5;276(40):37409-14
pubmed: 11473130
Proc Natl Acad Sci U S A. 2001 Mar 13;98(6):3577-82
pubmed: 11248120
Adv Protein Chem. 2003;66:27-85
pubmed: 14631816
Mol Pharmacol. 2021 Aug;100(2):61-64
pubmed: 34045267
Proc Natl Acad Sci U S A. 2010 Aug 17;107(33):14845-50
pubmed: 20682746
Proteins. 2002 May 15;47(3):393-402
pubmed: 11948792
J Biol Chem. 1997 Jan 31;272(5):2587-90
pubmed: 9006889
Pharmacol Ther. 2006 Jun;110(3):465-502
pubmed: 16460808
J Recept Signal Transduct Res. 2004 Aug;24(3):165-205
pubmed: 15521361
J Biol Chem. 2009 Dec 4;284(49):34103-15
pubmed: 19815545
Science. 1996 Nov 1;274(5288):768-70
pubmed: 8864113
Nature. 2020 Mar;579(7798):303-308
pubmed: 31945771
Nat Struct Mol Biol. 2018 Jan;25(1):4-12
pubmed: 29323277
Mol Psychiatry. 2020 Sep;25(9):2086-2100
pubmed: 30120413
Pharmacol Ther. 2005 Jun;106(3):405-21
pubmed: 15922020
Nature. 2020 Mar;579(7798):297-302
pubmed: 31945772
Proc Natl Acad Sci U S A. 2018 Jan 2;115(1):198-203
pubmed: 29255027
Mol Pharmacol. 2009 Jan;75(1):113-23
pubmed: 18809670
Biochem Pharmacol. 1973 Dec 1;22(23):3099-108
pubmed: 4202581
Nat Protoc. 2006;1(1):337-45
pubmed: 17406254
Proc Natl Acad Sci U S A. 2020 Jul 14;117(28):16346-16355
pubmed: 32601232
Mol Pharmacol. 2011 Aug;80(2):294-303
pubmed: 21596927
Proc Natl Acad Sci U S A. 2015 May 12;112(19):E2517-26
pubmed: 25918399
Pharmacol Res. 2016 Sep;111:1-16
pubmed: 27178731
Mol Pharmacol. 2008 Aug;74(2):371-8
pubmed: 18445708
J Biol Chem. 2001 Aug 3;276(31):29171-7
pubmed: 11375997
Elife. 2020 Oct 21;9:
pubmed: 33084570

Auteurs

Dayana Rodriguez-Contreras (D)

Research Service, VA Portland Health Care System, and Department of Behavioral Neuroscience, Oregon Health & Science University, Portland, Oregon 97239, United States.

Alec F Condon (AF)

Vollum Institute, Oregon Health & Science University, Portland, Oregon 97239, United States.

David C Buck (DC)

Research Service, VA Portland Health Care System, Portland, Oregon 97239, United States.

Naeem Asad (N)

New York University Abu Dhabi, Saadiyat Island, PO Box 129188, Abu Dhabi, United Arab Emirates.

Timothy M Dore (TM)

New York University Abu Dhabi, Saadiyat Island, PO Box 129188, Abu Dhabi, United Arab Emirates.

Dineke S Verbeek (DS)

Expertise Center Movement Disorders and Department of Genetics, University of Groningen, 9700 AB Groningen, The Netherlands.

Marina A J Tijssen (MAJ)

Expertise Center Movement Disorders and Department of Neurology, University of Groningen, 9700 AB Groningen, The Netherlands.

Ujwal Shinde (U)

Department of Chemical Physiology & Biochemistry, Oregon Health & Science University, Portland, Oregon 97239, United States.

John T Williams (JT)

Vollum Institute, Oregon Health & Science University, Portland, Oregon 97239, United States.

Kim A Neve (KA)

Research Service, VA Portland Health Care System, and Department of Behavioral Neuroscience, Oregon Health & Science University, Portland, Oregon 97239, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH